1. Introduction {#s0005}
===============

Cadmium (Cd) is a toxic metal massively released into the environment (\~30,000 tons/year) due to anthropogenic activities. Besides occupational exposure, Cd contamination in humans can occur through food, drinking water, inhalation of air particles, and cigarette smoking. It has been estimated that daily intake of Cd from food is generally between 8 and 25 μg ([@bb0130]). Cadmium ions (Cd^2+^) enter the cells through channels and transport pathways dedicated to essential ions, in what has been named a "Trojan horse mechanism" ([@bb0200]). Once absorbed, Cd is trapped in the body and evades detoxification leading to an estimated biological half-life of \>26 years. The accumulation of this metal contributes to the increase of oxidative stress and to the alteration of divalent ions homeostasis, primarily Zn^2+^ and Ca^2+^ ([@bb0030]); ([@bb0315]); ([@bb0335]); ([@bb0020]). Notably, about 3200 proteins (\~10% of the human proteome) require zinc to properly function, and, along with the ability of Cd to replace Zn in zinc-finger regions or zinc-domains functionally important for many proteins and enzymes ([@bb0225]); ([@bb0310]), these features suggest a role for Cd in essential metal dyshomeostasis, leading to alterations of physiological processes.

Cd is involved in global and site-specific DNA methylation, according to studies performed on model organisms ([@bb0115]) as well as in humans ([@bb0260]). Cd-associated epigenetic effects have also been studied in the context of other exposures such as smoking ([@bb0360]). Last but not least, Cd is a well-known carcinogen as classified by the International Agency for Research on Cancer, but the mechanisms underpinning the molecular processes are not completely clarified.

Cadmium carcinogenicity has been well demonstrated both in *in vitro* biological systems ([@bb0330]; [@bb0010]), such as the Cell Transformation Assays (CTAs), and in humans and animal models ([@bb0105]). The CTA is the most advanced *in vitro* assay for human carcinogenicity prediction induced by chemicals ([@bb0345]). It has been shown to closely model some *in vivo* key stages of the conversion of normal cells into malignant ones, and it is a powerful tool for mechanistic studies of carcinogenesis. Suitable cell lines are exposed to suspected carcinogens and, as a consequence of cell transformation, *foci* of transformed cells are formed after 3--6 weeks ([@bb0240]).

The CTA offers the unique advantage of studying in a standardized and controlled environment the signals that trigger chemical-induced carcinogenesis, and the biochemical processes and pathways deregulated in transformed cells (*foci)*. Furthermore, these assays are extremely important in the context of the 3Rs as they provide a means to reduce the use of animals, as CTA can be used to pre-screen for the potential of human carcinogens. Up to now, the use of alternative non-animal approaches, such as the CTA, in the context of carcinogenesis has been limited for different reasons, among which the lack of a complete comprehension of the carcinogenesis processes. Finally, even though the CTA should not be used as a stand-alone assay to predict carcinogenesis in the regulatory context, these assays are proposed as one of the building blocks in an integrated approach ([@bb0035]; [@bb0040]), thus stressing their importance in mechanistic studies and in hazard assessment.

The aim of this work is to investigate, through a toxicogenomic approach based on whole genome microarray analysis of gene expression and on a bioinformatics study, the differentially regulated genes in transformed cells from different *foci* obtained at the end of the *in vitro* cell transformation upon exposure of C3H10T1/2 cells to the same stimulus (1 μM CdCl~2~ 24 h treatment). The systematic analysis of deregulated genes and pathways in transformed cells, along with the comparison to what has previously been obtained by our group after the analysis of early responses to CdCl~2~ exposure in the same cell model ([@bb0060]; [@bb0020]), will provide a picture of triggering signals, of specific signatures and mechanistic processes in cadmium-induced cell transformation. Furthermore, these methods could represent a step forward in the development of a mechanistic-based approach for carcinogenesis alternative methods.

2. Materials and methods {#s0010}
========================

2.1. Cells and culture conditions {#s0015}
---------------------------------

The experiments were performed using the cells collected from Cd-transformed *foci* obtained at the end of Cell Transformation Assays (CTAs) on C3H10T1/2 clone 8 mouse embryonic fibroblasts (cell line ATCC, CCL 226 lot. n. 58078542). This cell line was chosen for its high sensitivity to carcinogenic compounds, its low spontaneous transformation rates, and because it represents one of the three cell lines suggested in the Detailed Review Paper on Cell Transformation Assay to be used for detection of chemical carcinogens ([@bb0240]). Cells with passages from 9 to 12 were used for cell transformation studies ([@bb0240]).

C3H cells were seeded at a density of 800 cells/dish in 100 mm diameter Petri dishes, and exposed 24 h after seeding to 1 μM CdCl~2~ for 24 h. Previous Cell Transformation Assays performed by our group ([@bb0330]) on a wide range of CdCl~2~ concentrations demonstrated that 1 μM CdCl~2~, which is below the cytotoxicity threshold (IC~50~ of 2.4 μM), is able to induce the formation of transformed *foci*. Samples treated with CdCl~2~ were exposed 4 days after the treatment to 0.1 μg/ml TPA (12-O-tetradecanoylphorbol-13-acetate), a known tumour promoter, in DMSO. TPA addition was maintained throughout all the experiments. Cells exposed to 0.1 μg/ml TPA alone were used as reference control. After 24 h of treatment, the cells were rinsed twice with phosphate buffered saline (PBS) and fresh medium was added. The medium was changed weekly. Upon confluence (around the 3rd week), high serum (10% FBS) medium was substituted with low (5% FBS) serum medium. The samples were observed weekly under a light microscope throughout the duration of the assay (6 weeks) to check healthy cells\' status and *foci* formation.

Different cell types were collected at the end of the CTAs, and the derived cell clones were cultured and processed for further analyses, as described in the following sections. The new cell clones were derived from three different fully transformed *foci,* all obtained after the initial exposure (24 h) to1 μM CdCl~2~, and classified as F1, F2, and F3.

Cells were cultured in Basal Medium Eagle (BME, Sigma Chemical Co., St. Louis, MO, USA) enriched with 10% heat-inactivated foetal bovine serum (FBS, Euroclone, Pero, Italy), 1% glutamine, 0.5% HEPES 2 M and 25 μg/ml gentamicin (all purchased from Sigma) at 37 °C in a humidified incubator supplied with a constant flow of 5% CO~2~ in air throughout each experiment. Cells were routinely seeded in 100 mm Ø Petri dishes, the medium was changed every 3 days and cells grown until 80% confluence maximum was reached. The cells were stored in ampoules, frozen at −80 °C with 10% sterile DMSO as a preservative.

2.2. RNA extraction and purification {#s0020}
------------------------------------

All cell clones were harvested by trypsinization at 80% confluence and lysed in 300 μl RLT buffer (Qiagen, Germantown, MD, USA), with 1:100 β-mercaptoethanol added. Homogenates were obtained by passing 5 times through a blunt 20-gauge needle fitted to a syringe. Samples were stored at −80 °C until RNA extraction was carried out.

RNA was purified from cell clones using the RNeasy Plus kit (Qiagen, Germantown, MD, USA). RNA was quantified using a ND-1000 UV--Vis Spectrophotometer (NanoDrop Technologies), and RNA integrity was assessed with the Agilent 2100 Bioanalyzer (Agilent), according to the manufacturer\'s instructions. RNA samples used in this study all had a 260/280 ratio above 1.9 and an RNA Integrity Number (RIN) above 9.0.

2.3. Microarray expression profiling and exploratory statistical analyses of the three foci {#s0025}
-------------------------------------------------------------------------------------------

In the microarray experiments, all sample-labelling, hybridization, washing, and scanning steps were conducted following the manufacturer\'s specifications. In brief, Cy3-labeled cRNA was generated from 500 ng input total RNA using Quick Amp Labeling Kit, One-colour (Agilent).

For every sample, 1.65 μg cRNA from each labelling reaction (with a specific activity above 9.0) was hybridized using the Gene Expression Hybridization Kit (Agilent) to the SurePrint G3 Mouse GE 8x60K Microarray (G4852, Agilent), which is an 8 × 60 k 60mer slide format. After hybridization, the slides were washed and then scanned with the Agilent G2565BA Microarray Scanner (Agilent). The fluorescence intensities on scanned images were extracted and pre-processed by Agilent Feature Extraction Software (v10.5.1.1). Quality control and array normalization was performed in the R statistical software environment using the Agi4x44PreProcess package downloaded from the Bioconductor web site ([@bb0075]). The normalization and filtering steps were based on those described in the Agi4x44PreProcess reference manual.

In order to detect differences in gene expression among different cell populations a moderate *t*-test was applied. Moderated *t* statistics were generated by the Limma Bioconductor package. Modulated genes were chosen as those with a fold change \>1 or smaller than −1 and a false discovery rate (Benjamini and Hochberg\'s method) corrected *p*-value smaller than 0.05 ([@bb0290]).

2.4. Quantitative real time-PCR {#s0030}
-------------------------------

RNA was reverse-transcribed using SuperScript® II RT (Invitrogen, Carlsbad, CA, USA), oligo dT and random primers, according to the manufacturer\'s protocol.

The SYBR Green method was used for quantitative real-time PCR (Q-PCR). Briefly, 50 ng cDNA was amplified with SYBR Green PCR Master Mix (Applied Biosystems, Foster City, CA, USA) and specific primers (100 nM), using an initial denaturation step at 95 °C for 10 min, followed by 40 cycles of 95 °C for 15 s and 59 °C annealing for 1 min. Each sample was analyzed for Interleukin 6 expression and normalized for total RNA content using β-actin gene as an internal reference control. The relative expression level was calculated with the Livak method (2\[-ΔΔC(T)\]) ([@bb0180]) and was expressed as a fold change ± standard deviation. The accuracy was monitored by the analysis of melting curves. The following primers were used: Interleukin 6 Fw 5′-AGCCAGAGTCCTTCAGAGAGA-3′ and Rv 5′-TGGTCTTGGTCCTTAGCCAC-3′; β-actin Fw 5′-CCACCATGTACCCAGGCATT-3′ and Rv 5′-CGGACTCATCGTACTCCTGC-3′.

2.5. Functional enrichment analysis {#s0035}
-----------------------------------

Differentially Expressed Genes (DEGs), namely up-regulated and down-regulated genes, were analyzed with WebGestalt (WEB-based Gene SeT AnaLysis Toolkit, <http://www.webgestalt.org>), to identify genes with similar functions ([@bb0375]). Enrichment analyses were conducted studying the Gene Ontology categories with a *p*-value lower than 0.05 in a hypergeometric test. The method used for enrichment analysis was the Over-Representation Analysis (ORA). WebGestalt gene tables summarization and volcano plots were used to summarize and visualize the enrichment results.

3. Results {#s0040}
==========

One of the purposes of the study was the identification of specific transcriptomic signatures able to unravel cadmium-induced carcinogenesis. In this regard, cDNA microarrays were used to analyze the modulation of gene expression induced by 1 μM cadmium chloride (CdCl~2~) at the end of Cell Transformation Assay (CTA) ([@bb0020]), using TPA-treated cells as a reference control. Thus, we performed a systematic analysis of the functions of up- and down-regulated genes in cells derived from three *foci* (F1, F2, and F3) to figure out a picture of cadmium promoted pathogenic mechanisms leading to cells transformation.

3.1. Differentially expressed genes (DEGs) in F1 focus {#s0045}
------------------------------------------------------

Among the top 15 up-regulated genes in F1 *focus*, listed in [Table 1](#t0005){ref-type="table"}, we found a series of genes involved in inflammation, such as *Cfh* gene coding for complement factor H, a major regulator of the alternative pathway of the complement system, which is able to bind neutrophiles, macrophages and monocytes with a proinflammatory effect ([@bb0135]). In addition, through a function not related to its complement-regulatory capacity, receptor-bound factor H can mediate or regulate cell adhesion.Table 1List of top 15 up- and down-regulated genes in cells from F1 *focus*. DEGs are listed in descending order of fold change compared to TPA-treated cell clone.Table 1GeneNameDescriptionFold changechr10:119960546-119979696_FlincRNA: chr10:119960546-119979696 forward strand12.34Cfhcomplement component factor h (Cfh)5.27Pddc1Parkinson\'s disease 7 domain containing 14.56Tgtp2T cell specific GTPase 24.25Lumlumican3.96Hdac9histone deacetylase 9 (Hdac9), transcript variant 23.88Capn6calpain 63.84ENSMUST00000099684Unknown3.73ENSMUST00000099050Unknown3.52FosbFBJ osteosarcoma oncogene B3.48H2-K1histocompatibility 2, K1, K region, transcript variant 13.44Spp1secreted phosphoprotein 1, transcript variant 53.36ENSMUST00000099042Unknown3.34Ear2eosinophil-associated, ribonuclease A family, member 23.27A_55_P1987086Unknown3.25Mt2metallothionein 2-4.78Thbdthrombomodulin-4.89Trnp1TMF1-regulated nuclear protein 1−5.21Hspb1heat shock protein 1-5.23Smpdl3asphingomyelin phosphodiesterase, acid-like 3A-5.26Mestmesoderm specific transcript, transcript variant 1-5.28Hs6st2heparan sulfate 6-O-sulfotransferase 2-5.34Gm54939 days embryo whole body cDNA, RIKEN full-length enriched library, clone: D030063M22 product: weakly similar to Hypothetical KRAB box containing protein-5.41MgmtO − 6-methylguanine-DNA methyltransferase-5.53Slit3slit homolog 3 (*Drosophila*)-5.90Gas6growth arrest specific 6−6.20Pcp4Purkinje cell protein 4−6.53Mestmesoderm specific transcript, transcript variant 2-6.94Slc17a3solute carrier family 17 (sodium phosphate), member 3−7.66Rspo3R-spondin 3 homolog (*Xenopus laevis*)−8.13

Another gene involved in inflammation is *Spp1* gene coding for Osteopontin (also known as optineurin), a cytokine and cell attachment phosphoprotein expressed by various tissues and cell types and involved in multiple functions such as inflammation, cell adhesion, migration and tumour invasion. In particular, osteopontin is known to up-regulate MMP-2 expression and activity in tumour cells ([@bb0400]) and may act as a potent angiogenic factor ([@bb0410]). Another transcript related to inflammation is the T-cell specific GTPase 2 isoform X1, coded by *Tgtp2*, which has been demonstrated to be involved in systemic inflammatory response syndrome (SIRS) ([@bb0210]), as well as in antiviral response ([@bb0025]).

Lumican, coded by up-regulated *Lum* gene, is a member of the small leucine-rich proteoglycan family, expressed in the extracellular matrix of different tissues, where **i**t plays a critical role in collagenous matrix assembly, protecting collagen from cleavage by matrix metalloproteinase-9 (MMP-9) ([@bb0190]). Its ability to down-regulate the proteolytic activity associated with endothelial cell membranes, particularly MMP-14 and MMP-9, gives Lumican angiostatic properties.

Other up-regulated genes code for proteins involved in cell proliferation, migration and invasion, like FBJ osteosarcoma oncogene B (coded by *Fosb* gene) which promotes cell survival, and Histone deacetylase (coded by *Hdac9* gene), a negative regulator of adipogenic differentiation, whose over-expression has been documented in several malignancies.

*Capn6*, encoding for Calpain 6 (CAPN6), was also found to be up-regulated in cells from F1 *focus*. Unlike the other members of the family, CAPN6 is not a proteolytic enzyme ([@bb0050]), since it lacks the active-site catalytic cysteine residue. Instead, it has been shown to modulate osteoclasts and stabilize microtubules ([@bb0325]).

Among the 15 top down-regulated genes in cells from F1 *focus* (also listed in [Table 1](#t0005){ref-type="table"}) we found *Rspo3* gene, a homolog of *Xenopus laevis R-spondin 3* gene. R-spondins (RSPO) are agonists of the Wnt pathway, interfering with the clearance of Wnt receptors from the plasma membrane ([@bb0055]). RSPO3 expression has been shown to cause rapid development of adenoma and adenocarcinoma in the intestine, establishing RSPO3 as an efficient, causal driver of intestinal cancer ([@bb0110]).

Another interesting down-regulated gene, *Slc17a3*, coding for a member of solute carrier family 17 (sodium phosphate), isoform CRA_c.

*Mest* gene, which was down-regulated in cells from all the three *foci*, codes for mesoderm-specific transcript protein isoform 1 precursor (MEST), a putative alpha/beta hydrolase, although the substrate of this enzyme has not yet been identified ([@bb0145]). A functional role related to oncofetal angiogenesis has been suggested for the MEST proteins ([@bb0215]).

PEP-19/pcp4 is a neuron-specific peptide in the adult brain, binding to the C-domain of calmodulin; a role for PEP-19/pcp4 as a regulator of synaptic plasticity in the mouse striatum, in the context of spatial learning, has recently been proposed ([@bb0005]).

*Gas6* gene, coding for growth arrest specific 6 protein, was found to be down-regulated also in cells from F2 and F3 *foci*. Gas6 protein activates STAT3 signalling and stimulates the molecular process of differentiation or myelination in the adult optic nerve ([@bb0095]). Moreover, other authors ([@bb0265]) found that the complete deletion of the Gas6 signalling pathway significantly impacted resolution of inflammation, axonal integrity and remyelination. Gas6 therefore seems to have an anti-inflammatory effect and a role in cell differentiation, its down-regulation likely leading to loss of differentiation and inflammation.

*Slit3* gene, also down-regulated in F1 *focus*, codes for a member of the Slits proteins, large matrix proteins that are secreted by endothelial cells. Slit3 was reported to enhance monocyte migration *in vitro*, as well as myeloid cell recruitment *in vivo* and to induce the activation of RhoA, a member of the Rho family of small GTPases ([@bb0080]).

*Mgmt* gene codes for O-6-methylguanine-DNA methyltransferase (MGMT), a DNA alkyl transferase; a role in the development of certain kinds of human tumours is suggested by the observation that *Mgmt* gene is silenced by promoter methylation in gliomas, colorectal tumours, non-small-cell lung carcinoma, lymphomas and head and neck cancers ([@bb0195]).

Heparan sulfate 6-O-sulfotransferase 2 (HS6ST2), transcript variant 2, coded by *Hs6st2* gene, belongs to the HS6ST family, comprising different isoforms with distinct substrate preferences. HS6ST-1-deficiency is lethal to mice mostly at later embryonic stages, leading to various malformations in muscle development ([@bb0100]).

*Smpdl3a* gene codes for sphingomyelin phosphodiesterase acid-like 3A (SMPDL3A), a di‑zinc-dependent enzyme, which, in contrast to sphingomyelinase, is inactive against sphingomyelin and can instead hydrolyze nucleoside diphosphates and triphosphates, which may play a role in purinergic signalling ([@bb0090]).

TMF-1 regulated nuclear protein 1 (TRNP1), coded by *Trnp1* gene, is a basic protein which accumulates in an insoluble nuclear fraction in mammalian cells, that can accelerate cell cycle progression ([@bb0365]).

Another down-regulated gene in cells from F1 *focus* is *Thbd*, coding for thrombomodulin (TM), a protease with a role in TM dependent protein C activation, essential for mitochondrial function and myelination in CNS ([@bb0390]). Loss of TM-dependent PC generation impairs primarily mitochondrial function and not mitochondrial biogenesis, suggesting a protective role for TM in CNS against oxidative stress.

Two more genes, *Mt2* and *Hspb1* coding for metallothionein 2 and heat shock protein 1 respectively, are down-regulated in cells from F1 *focus*.

3.2. Differentially expressed genes (DEGs) in F2 focus {#s0050}
------------------------------------------------------

[Table 2](#t0010){ref-type="table"} lists the top 15 up-regulated and down-regulated genes in cells from F2 *focus*. Among the most up-regulated genes, we found *Efemp1*, coding for the glycoprotein fibulin-3, which is normally expressed along the primary olfactory pathway and produced by olfactory epithelium cells *in vitro* ([@bb0370]). Fibulin-3 belongs to a small family of glycoproteins that normally have widespread distribution in extracellular matrix structures such as basement membranes, microfibrils and elastic fibres ([@bb0015]; [@bb0320]; [@bb0355]). Based on its interaction with the tissue inhibitor of metalloproteinases-3 (TIMP-3) ([@bb0150]), a critical role for fibulin-3 in regulating matrix metalloproteinase (MMP) activity has been proposed ([@bb0220]). Manipulation of fibulin-3 expression in cultured olfactory epithelium cells has been shown to alter both proliferation and migration ([@bb0370]).Table 2List of top 15 up- and down-regulated genes in cells from F2 *focus*. DEGs are listed in descending order of fold change compared to TPA-treated cell clone.Table 2GeneNameDescriptionFold changeEfemp1epidermal growth factor-containing fibulin-like extracellular matrix protein 14.1Rasal3RAS protein activator like 34.04Fstl4follistatin-like 43.97ENSMUST00000188511tc\|Q5SR98_MOUSE (Q5SR98) Ortholog of human Ras association (RalGDS\\/AF-6) and pleckstrin homology domains 1 RAPH1 (Fragment), complete \[TC1598183\]3.86chr14:26093652--26,208,156_RlincRNA: chr14:26093652--26,208,156 reverse strand3.61Chatcholine acetyltransferase3.51chr18:63480341--63,480,899_RlincRNA: chr18:63480341--63,480,899 reverse strand3.51D6Ertd527eDNA segment, Chr 6, ERATO Doi 527, expressed, transcript variant 13.45ENSMUST00000181143RIKEN cDNA B230104I21 gene (B230104I21Rik), misc_RNA3.25Xlr3bX-linked lymphocyte-regulated 3B3.24Resp18regulated endocrine-specific protein 183.14Ccl2chemokine (C---C motif) ligand 23.08Spp1secreted phosphoprotein 1, transcript variant 52.97Olfml2aolfactomedin-like 2A2.96chr2:150496011--150,496,503_RlincRNA: chr2:150496011--150,496,503 reverse strand2.932610008E11RikRIKEN cDNA 2610008E11 gene−3.97Hyihydroxypyruvate isomerase homolog (*E. coli*), transcript variant 1−3.98Gstt3glutathione S-transferase, theta 3−4.14Olfr464olfactory receptor 464−4.30Mestmesoderm specific transcript, transcript variant 1−4.71Fbln7fibulin 7−4.75Scrn1secernin 1−4.88Hspb1heat shock protein 1−4.96Gm54939 days embryo whole body cDNA, RIKEN full-length enriched library, clone: D030063M22 product: weakly similar to Hypothetical KRAB box containing protein (Fragment) \[*Mus musculus*\], full insert sequence−5.12MgmtO-6-methylguanine-DNA methyltransferase−5.21Thbdthrombomodulin−5.35Rspo3R-spondin 3 homolog (*Xenopus laevis*) (Rspo3),−5.37ENSMUST00000019268mRNA for mKIAA0193 protein−5.63Mestmesoderm specific transcript, transcript variant 2−6.06Slc17a3solute carrier family 17 (sodium phosphate), member 3, transcript variant 1−7.88

Ras-activating protein-like 3 (RASAL3), encoded by *Rasal3* up-regulated gene, is a T cell-specific Ras GTPase-activating protein, that negatively regulates T cell receptor (TCR)-induced activation of Ras/MAPK pathway. Collectively, RASAL3 controls the magnitude of inflammatory responses through the survival of both naive T cells and activated T cells *in vivo* ([@bb0235]).

Follistatin-like 4, a SPARC-related protein-containing immunoglobulin domains 1 (SPIG1) encoded by *Fstl4* gene, was identified as one of the dorsal-retina-specific molecules expressed in the developing chick retina. SPIG1 negatively regulates Brain Derived Neurotrophic Factor maturation, thereby suppressing axonal branching and spine formation ([@bb0305]).

Other up-regulated genes in cells from F2 *focus* are *Chat*, coding for choline acetyltransferase, *Xlr3b*, coding for X-linked lymphocyte-regulated 3B, and *Resp18*, coding for Regulated endocrine-specific protein,18 kDa; the latter is a unique endoplasmic reticulum resident protein with an unknown function, first identified as a dopaminergic drugs-regulated intermediate pituitary transcript.

Also related to immunological signalling is *Ccl2* gene, coding for chemokine (C---C motif) ligand 2 (previously named MCP-1), one of the most important members of the CC chemokines family, involved in the regulation of oriented migration and the infiltration of mainly reticuloendothelial system cells, specifically monocyte/macrophage phenotypes. Fundamental roles are played by CCL2 and its related receptor (the CCR2) in brain tumours and in migration of monocytes from the bloodstream through the vascular endothelium ([@bb0340]). CCL2 is a potent monocyte-attracting chemokine and greatly contributes to the recruitment of blood monocytes into sites of inflammatory responses and tumours. Although tumour cells are considered to be the main source of CCL2, various non-tumour cells in the tumour stroma also produce CCl2 in response to stimuli.

*Spp1* gene coding for Osteopontin is up-regulated also in cells from F2 *focus*. The last up-regulated gene with a known function, *Olfml2a*, codes for olfactomedin-like 2A, belonging to the OLF (olfactomedin)-family, a major component of the extracellular mucus matrix of olfactory neuroepithelium ([@bb0065]).

Among the top 15 down-regulated genes in cells from F2 *focus* we found many genes which are also down-regulated in F1 *focus*, such as *Slc17a3*, *Mest*, *Rspo3*, *Thbd*, *Mgmt*, *Hspb1*, as well as *Gm5493* gene, whose product is unknown.

Among the genes exclusively up-regulated in F2 *focus* we found *Scrn1*, coding for Secernin 1, a brain cytosolic protein, with a putative dipeptidase activity, also capable of regulating exocytosis in permeabilized mast cells ([@bb0380]), and *Fbln7*, coding for fibulin-7 (FBLN7), also called TM14, a cell adhesion molecule that interacts with extracellular matrix molecules in teeth ([@bb0350]). Argraves and coworkers ([@bb0015]) described the first member of this family, fibulin-1, as a binding partner for the fibronectin receptor integrin and an important regulator of cell adhesion. So far, 5 other members (fibulins 2--6) have been identified, modulating cell morphology, growth, adhesion, and motility. In addition, it has been demonstrated that the dysregulation of some fibulins is linked to cancer, and both tumour suppressive and pro-oncogenic roles have been proposed for members of the fibulin family ([@bb0070]).

3.3. Differentially expressed genes (DEGs) in F3 focus {#s0055}
------------------------------------------------------

As shown in [Table 3](#t0015){ref-type="table"}, among the 15 top up-regulated genes in F3 *focus*, we found a series of genes coding for 2′-5′ oligoadenylate synthetases (OAS), such as *Oas1a*, *Oas1f*, *Oas2* and *Oasl2*. OAS proteins are interferon (IFN) inducible pathogen recognition receptors expressed in different cell types. Upon activation by the pathogen-associated molecular pattern (PAMP) double-stranded viral RNA, certain OAS proteins synthesize 2′-5′- oligoadenylate (2-5A), which activates RNase L ([@bb0285]). In mice, there are 8 *Oas1* genes ([@bb0205]; [@bb0245]; [@bb0160]); however, only *mOAS1a* and *mOAS1g* are believed to be enzymatically active. Mice have four additional *Oas* genes, which produce 3 enzymatically active proteins (mOAS2, mOAS3 and mOASL2), and one inactive (mOASL1) protein ([@bb0140]).Table 3List of top 15 up- and down-regulated genes in cells from F3 *focus*. DEGs are listed in descending order of fold change compared to TPA-treated cell clone.Table 3GeneNameDescriptionFold changeOas1a2′-5′ oligoadenylate synthetase 1A7.68Oas1f2′-5′ oligoadenylate synthetase 1F6.31Oas22′-5′ oligoadenylate synthetase 26.09Ifi44interferon-induced protein 445.58Gm9706predicted gene 97065.54Sp110Sp110 nuclear body protein5.48Mx1myxovirus (influenza virus) resistance 15.39Oasl22′-5′ oligoadenylate synthetase-like 25.38Isg15ISG15 ubiquitin-like modifier5.30H2-K1histocompatibility 2, K1, K region5.30LOC100041034Sp110 nuclear body protein-like5.30Ifi27l2ainterferon, alpha-inducible protein 27 like 2A5.24Tgtp2T cell specific GTPase 25.19Usp18ubiquitin specific peptidase 184.97Rtp4receptor transporter protein 44.90Papss23′-phosphoadenosine 5′-phosphosulfate synthase 2−3.20Mestmesoderm specific transcript−3.21Ppp1r1bprotein phosphatase 1, regulatory (inhibitor) subunit 1B−3.23Rpe65retinal pigment epithelium 65−3.28Col11a1collagen, type XI, alpha 1−3.37Speer2spermatogenesis associated glutamate (*E*)-rich protein 2−3.421190002H23RikRIKEN cDNA 1190002H23 gene−3.47Sorl1sortilin-related receptor, LDLR class A repeats-containing−3.654933402N22RikRIKEN cDNA 4,933,402 N22 gene−3.67Arxes2adipocyte-related X-chromosome expressed sequence 2−3.72Plxdc2plexin domain containing 2−3.82Pcp4Purkinje cell protein 4−4.01Igf1insulin-like growth factor 1−4.54FosFBJ osteosarcoma oncogene−4.56Col2a1collagen, type II, alpha 1−6.72

With two exceptions, namely *Usp18* and *Rtp4*, all other genes up-regulated in cells from F3 *focus* code for proteins involved in IFN mediated antiviral response: *Ifi44*, coding for interferon-induced protein 44; *Sp110*, coding for Sp110 nuclear body protein, an interferon induced transcriptional coactivator with a bound zinc atom highly expressed in leukocytes; *Mx1*, coding for myxovirus resistance 1 protein; *Isg15*, coding for ISG15 ubiquitin-like modifier; H2-K1, histocompatibility K region; *Ifi27l2a*, coding for interferon alpha-inducible protein27 like 2A, and *Tgtp2*, coding for T cell specific GTPase 2. Ifi2712a belongs to a family of small interferon induced hydrophobic proteins, the ISG12 proteins; the expression of *ISG12b1*, also called *IFI27*, has been reported to be up-regulated in the mouse brain after intracerebral virus infection. Moreover, *ISG12b1* has been identified as an adipose-specific gene, localized in mitochondria: current studies demonstrate that its overexpression in 3 T3-L1 cells inhibits mitochondrial biogenesis and lipid accumulation in adipocytes ([@bb0175]).

*Usp18* codes for ubiquitin-specific protease 18, a deubiquitinating enzyme (DUB) catalysing the deconjugation of ubiquitin chains from ubiquitinated proteins ([@bb0155]). Many studies have demonstrated that some DUBs are the signalling targets of cellular stress such as oxidative stress. In mouse, *Usp18* was found to be induced by oxidative stress, in a dose- and time-dependent manner, while its depletion could stimulate an increase in p53 and caspase 3 protein levels. This suggests that *Usp18* protects the cells from oxidative stress-induced apoptosis, likely through the regulation of p53 and caspase 3 ([@bb0170]). DUBs can regulate p53 signalling pathway *via* different mechanisms within different cellular compartments in response to different kinds of stresses ([@bb0165]).

*Rtp4* codes for receptor transporter protein 4, a member of the RTP protein family specifically expressed in olfactory neurons. These proteins are normally associated with olfactory receptors (OR) proteins and enhance OR responses to odorants ([@bb0275]).

Among the top 15 genes down-regulated in cells from F3 *focus*, also listed in [Table 3](#t0015){ref-type="table"}, we found the *Mest* gene, which is found among the 15 top down-regulated genes of cells from F1 and F2 *foci*. Two genes coding for collagen, *Col2a1* and *Col11a1* are also down-regulated in this *focus*, as well as *Pcp4* gene, which is one of the most strongly down-regulated genes in F1 *focus*. Interestingly, *Fos* gene, promoting cell survival, was found to be down-regulated in F3 *focus*, while it is found among the most up-regulated genes in F1 *focus*. The same is true for *Igf1* gene, coding for insulin-like growth factor 1, which plays a key role in the development and progression of many human cancers. Moreover, a large amount of data supports that insulin-like growth factor 1 (IGF-1) deficiency increases insulin resistance, impairs lipid metabolism, promotes oxidative damage, and dysregulates the GH/IGF-1 axis ([@bb0085]).

Another down-regulated gene in cells from F3 *focus* is *Plxdc2* gene, coding for plexin domain containing 2. Direct molecular activity of Plxdc2 has been demonstrated in the control of proliferation, its expression being altered in various kinds of cancer; in particular, Plxdc2 has been shown to act as a mitogen in the developing nervous system ([@bb0230]).

*Arxes2* gene, coding for adipocyte-related X-chromosome expressed sequence 2, is required for fat cells differentiation and is transactivated by adipogenic transcription factors.

*Sorl1* gene codes for sortilin-related receptor, an LDLR class A receptor with a cysteine-rich repeat that plays a central role in mammalian cholesterol metabolism, as well as in cell migration and metabolic regulation ([@bb0280]).

*Speer2* gene codes for spermatogenesis associated glutamate (*E*)-rich protein 2, a new group of haploid sperm-specific nuclear factors ([@bb0295]).

RPE65, the product of *Rpe65* gene, is an enzyme involved in vitamin A metabolism in retinal pigment epithelium (RPE) cells ([@bb0270]), where it is necessary for production of 11-cisvitamin A in the retinal visual cycle. Mutations in *Rpe65* are associated with several retinal disorders. Pyakurel and coworkers demonstrated that the disruption of ERK1/2 specifically in RPE cells leads to a marked decrease of RPE65 expression, while the activation of ERK1/2 is associated with the activation of the Wnt/β-catenin pathway, which plays a key role in the expression of the RPE-specific transcription factors ([@bb0255]).

Two more genes were found down-regulated in cells from F3 *focus*: *Papss2*, coding for 3′-phosphoadenosine 5′-phosphosulfate synthase 2, and *Ppp1r1b* encoding protein phosphatase, inhibitor subunit 1b, a bifunctional signal transduction molecule.

3.4. Cytokines encoding genes are up-regulated in cells from all foci {#s0060}
---------------------------------------------------------------------

The Venn Diagram in [Fig. 1](#f0005){ref-type="fig"}A shows the number of the differentially expressed genes (DEGs) in the cells from the three *foci*. On the whole, cells from F3 *focus* undergo the highest gene expression deregulation, with 1091 DEGs, while cells from F2 seem to be the less changed by Cd treatment, with only 126 DEGs; the cells from F1 *focus* present an intermediate situation with 255 DEGs. Only 34 genes are deregulated in all three *foci*, although not to the same extent, and are all listed in [Table 4](#t0020){ref-type="table"} and graphically represented in [Fig. 1](#f0005){ref-type="fig"}B. [Table 4](#t0020){ref-type="table"} shows that the only genes up-regulated in all three *foci* are genes coding for cytokines: *Ccl2*, *Ccl5*, *Il6* and *Spp1*. Among the 34 DEGs common in all *foci*, the majority (23) appears to be down-regulated in all *foci*, while only 4 are down-regulated in both F1 and F2 *foci* and up-regulated in F3 *focus*; only one gene (*Marcksl1*, coding for MARCKS-like 1 protein) is up-regulated in both F1 and F2 *foci* and down-regulated in F3 *focus*, while *Thy1* gene, coding for thymus cell antigen 1, is down-regulated in F1 *focus* and up-regulated in both F2 and F3 *foci*.Fig. 1Differentially expressed genes (DEGs) in the three different *foci* (F1, F2, and F3) analyzed: A) Venn Diagram of DEGs (both up and down) for the three *foci*; B) Plot of fold change (FC) on y-axis of the genes differentially expressed in all the three *foci* (see [Table 4](#t0020){ref-type="table"}). Colours represent the three different *foci*. Genes are ordered by the comparison F1 *vs* TPA.Fig. 1Table 4Differentially expressed genes in all cell clones from F1, F2, and F3 *foci.*Table 4Gene nameDescriptionFold changeF1F2F32810405K02RikRIKEN cDNA 2,810,405 K02 gene−2.94−2.311.27Arhgap20Rho GTPase activating protein 20−2.85−2.02−1.32Ccl2chemokine (C---C motif) ligand 22.413.082.50Ccl5chemokine (C---C motif) ligand 52.922.454.54Cd302CD302 antigen−4.24−3.892.33Col11a1collagen, type XI, alpha 1−4.32−2.90−3.37Col2a1collagen, type II, alpha 1−3.24−2.77−6.72Ctgfconnective tissue growth factor−3.55−2.66−1.85Ctshcathepsin H−4.69−3.481.30Dnerdelta/notch-like EGF-related receptor−3.76−2.60−2.05Frmd3FERM domain containing 3−2.60−2.31−2.50Fxyd6FXYD domain-containing ion transport regulator 6−4.07−3.21−1.27Gas6growth arrest specific 6−6.20−2.85−1.98Hebp2heme binding protein 2−4.54−2.113.18Hyihydroxypyruvate isomerase homolog (*E. coli*)−4.17−3.98−1.26Il6interleukin 62.392.323.18Irak3interleukin-1 receptor-associated kinase 3−2.25−2.13−1.37Marcksl1MARCKS-like 12.272.19−1.19Mestmesoderm specific transcript−6.94−6.06−3.21MgmtO-6-methylguanine-DNA methyltransferase−5.53−5.21−1.40Mt2metallothionein 2−4.78−3.12−1.99Npy1rneuropeptide Y receptor Y1−4.26−3.92−1.65Ntrk2neurotrophic tyrosine kinase, receptor, type 2−2.25−2.27−1.40Papss23\'-phosphoadenosine 5\'-phosphosulfate synthase 2−3.62−2.79−3.20Pcp4Purkinje cell protein 4−6.53−3.63−4.01Ppp1r1bprotein phosphatase 1, regulatory (inhibitor) subunit 1B−3.64−2.68−3.23Prickle1prickle homolog 1 (*Drosophila*)−4.46−2.80−1.89Rpe65retinal pigment epithelium 65−3.78−2.45−3.28Rspo3R-spondin 3 homolog (*Xenopus laevis*)−8.13−5.37−2.23Scrn1secernin 1−4.46−4.88−1.61Sfrp2secreted frizzled-related protein 2−4.72−3.64−2.21Slc35f1solute carrier family 35, member F1−2.54−2.98−2.60Spp1secreted phosphoprotein 13.362.973.83Thy1thymus cell antigen 1, theta−3.782.483.28

The validation through RT-PCR confirmed *Il-6* gene up-regulation in all three *foci*. The relative quantification of Interleukin-6 mRNA was carried out through real-time quantitative PCR in cells from all three *foci*, using *β*-actin as internal reference control, and TPA-treated cells as a calibrator. The results, reported in [Fig. 2](#f0010){ref-type="fig"}, showed *Il-6* gene to be up-regulated in all three *foci*, with a higher fold change in F1 *focus*, compared to both F2 and F3 *foci*.Fig. 2Relative quantification of Interleukin-6 mRNA levels by real-time quantitative PCR in F1, F2, F3 cell clones.The relative expression level was calculated with the Livak method (2\[−ΔΔC(T)\]) and was expressed as a fold change ± SD, using β-actin gene as internal reference control and the TPA-treated cell clone as calibrator. \*\*\* *P* \< 0.001 (Dunnett's test).Fig. 2

3.5. Gene Ontology enrichment analysis {#s0065}
--------------------------------------

The DEGs detected in microarrays from the three *foci* were subjected to a Gene Ontology (GO) enrichment analysis, as described in Materials and Methods. Results reported in [Fig. 3](#f0015){ref-type="fig"} show the presence, in all *foci,* of dysregulated gene expression in the "angiogenesis" category, which includes some up-regulated genes, like *Spp1*, coding for osteopontin, or down-regulated genes, like *Mest* and *Plxdc2*. Other categories showing dysregulated genes in all *foci* concern organ and tissue morphogenesis, as well as extracellular organization; however, none of these categories is common to all *foci*. Dysregulated genes in "extracellular structure organization" are found in F2 and F3 *foci* ([Fig. 3](#f0015){ref-type="fig"}B and 3C), but not in F1 ([Fig. 3](#f0015){ref-type="fig"}A). However, F1 *focus* shows dysregulated genes in connective tissue, muscle organ and skeletal system development, as well as in "regulation of animal morphogenesis", "extracellular organization" and "tissue morphogenesis" ([Fig. 3](#f0015){ref-type="fig"}A). Moreover, only F1 *focus* shows dysregulation of genes related to negative regulation of growth, a category including many growth factors, as well as different chemokines and interleukins, leading to a loss of growth regulation.Fig. 3Functional enrichment analysisEach volcano plot shows the log of False Discovery Rates (FDR) against enrichment ratio for all the Gene Ontology categories. The gene set name showed in the volcano plot are representative of the TOP 10 categories based on the FDR. For example, the most significant categories are shown in the upper part of the plots. The size and colour of the dots are proportional to the size of the category. Volcano plots represent the Enrichment results of F1 (A), of F2 (B), and of F3 cell clones (C).Fig. 3

Apart from genes involved in regulation of cell morphogenesis, skeletal system development and extracellular structure organization, most of dysregulated genes in F3 *focus* belong to categories related to immune defence, like "regulation of innate immunity response", "response to virus", "positive regulation of defence response", "response to beta and gamma interferons" ([Fig. 3](#f0015){ref-type="fig"}C).

As shown in [Fig. 3](#f0015){ref-type="fig"}B, some dysregulated genes related to immune response are also found in F2 *focus* in the "chemiotaxis" category, including chemokines coding genes, as well as *Gas6* and *Fgf4* genes.

4. DISCUSSION {#s0070}
=============

Comparing the lists of differentially expressed genes (DEGs) in the cells from the three *foci*, it is evident that a common stimulus (1μM CdCl~2~ for 24h) administered to the healthy C3H10T1/2 cells elicits different cellular responses, as preliminarily shown by our group ([@bb0060]). Most of the cells treated with CdCl~2~ have efficient defence mechanisms, demonstrated by the up-regulation of metallothioneins and Hsp70 in the first hours after cadmium administration, followed by their down-regulation ([@bb0020]). However, a few cells, cannot efficiently counteract the insult and develop different metabolic alterations ([@bb0060]), leading to cell transformation and *foci* formation in the weeks following cadmium treatment.

DEGs analysis, performed in this work, confirms these differences, showing only 34 common DEGs in cells from the different *foci*; among these, only 4 genes are up-regulated in all *foci*: *Ccl2*, *Ccl5*, *IL6* and *Spp1*, all coding for chemokines. Although chemokines were first discovered as mediators of migration of immune cells to sites of inflammation and injury, they are now known to play multiple roles in organ development, angiogenesis, and tumorigenesis. In particular, recent data show that CCl2 production regulates the interactions between tumour cells and macrophages, promoting tumour progression ([@bb0395]).

Gene Ontology (GO) enrichment analysis, performed on all DEGs in the three *foci,* shows that inflammation, and therefore cytokines production, is involved in many of the identified pathways, like "cell chemiotaxis", "positive regulation of defence response", "response to viruses" and "regulation of immune innate response". The up-regulation of inflammatory pathways is less evident in F1 *focus*, where genes connected with up-regulation of cell growth and extracellular matrix rearrangement prevail, in accordance with its highly proliferative behaviour; this confirms data from a previous work by our group ([@bb0060]), showing that, while the ERK proliferative pathway is activated in F1 *focus*, the survival pathway mediated by Akt is activated in F3 *focus*. The down-regulation of both *Fosb* and *Igf1* genes in F3 *focus*, as well as the up-regulation of *Fosb* gene in F1 *focus*, likely accounts for this difference in proliferation.

On the other hand, we found that most common DEGs are down-regulated; among these, are genes coding for proteins of the extracellular matrix, like *Mest*, *Col11a1*, *Col2a1* and *Ctgf*, and genes coding for proteins involved in cell growth arrest, such as *Gas6*, *Rspo3* and *Mgmt*. suggesting major rearrangements of the extracellular matrix leading to cell cycle progression. A major rearrangement of extracellular matrix is confirmed also by GO analyses, showing "regulation of animal morphogenesis", "connective tissue development", as well as "regulation of cell morphogenesis" and "extracellular structural organization" among the most deregulated pathways.

On the whole gene expression dysregulation induced by CdCl~2~ seems to be achieved more through gene down-regulation than up-regulation: in F1 *focus*, apart from the most up-regulated gene (showing a fold change higher than 12), the other top up-regulated genes show an average fold of 4, in contrast with the top down-regulated genes, all showing folds higher than 5. The same is true for F2 *focus*, although with smaller overall fold values, showing higher values for top down-regulated genes than for up-regulated ones. In contrast, in F3 *focus*, the top 15 up- and down-regulated genes show similar fold values.

F1 and F2 *foci* are more similar to each other than to F3 *focus*, showing 8 identical top down-regulated genes out of 15. An intriguing feature of F2 *focus* is the down-regulation of two genes coding for olfactory receptors (OR); many other OR encoding genes were previously found to be down-regulated upon 24 hours treatment with cadmium ([@bb0020]). Although the meaning of this down-regulation is not clear, about 1500 genes coding for olfactory receptors are present in mouse genome and these receptors are also expressed in a variety of non-olfactory tissues ([@bb0405]; [@bb0125]; [@bb0250]). Moreover, several predicted mammalian OR genes are solely expressed in non-olfactory tissues, raising the possibility that the receptors have functions other than odour recognition. Although still debated, OR are probably either Zn or Cu binding proteins, their dysregulation being due to Zn/metals homeostasis disruption.

Although significant differences are observed when comparing F1 and F2 top up-regulated genes, the only common DEG being *Spp1*, on the whole, the same pattern of cell matrix rearrangement and inflammatory response up-regulation emerges in cells from both *foci*, involving genes such as *Mest*, *Lum*, *Slit3* and *Hs6st2*, *Efemp1*, *Fbln7*, coding for cell matrix proteins, and *Spp1*, *Cfh*, *Tgtp2*, *Rasal3*, *Resp18*, *Ccl2* and *Xlr3b*, involved in inflammation. Moreover, many proteins encoded by DEGs have been previously reported to be oncogenic, like *Fosb, Hdac9* and *Gas6,* dysregulated in F1 *focus*, and *Mgmt, Rspo3* and *Thbd,* dysregulated in both F1 and F2 *foci*.

A completely different picture emerges from the top up- and down-regulated genes in F3 *focus*; in particular, 13 out of the 15 top up-regulated genes are involved in an interferon mediated antiviral response, which can be triggered by either viral DNA or viral RNA. Efficient elimination of viral infection relies on both detection of the virus by pattern recognition receptors (PRRs) and inhibition of viral replication by antiviral restriction factors. Retinoic acid-inducible gene-I (*RIG-I*) is a PRR that upon activation by primarily 5'-triphosphate RNA induces a signalling cascade leading to interferon (IFN) gene expression.

The 2'-5' oligoadenylate synthetases (OASs) are a family of IFN- and virus-induced antiviral restriction factors that provide protection against a wide spectrum of RNA and DNA viruses. Initial virus detection induces the expression of OASL, which, upon subsequent virus detection, can promote RIG-I signalling thereby enhancing the antiviral response ([@bb0120]). However, a similar response has been shown to be triggered also by mitochondrial damage releasing mtDNA into the cytosol. *Thbd* gene down-regulation in both F1 and F2 *foci* also suggests mitochondrial damage, loss of Thrombomodulin-dependent PC activation impairing mitochondrial functionality. GO enrichment analysis confirms the strong up-regulation of inflammatory response in F3 *focus*, showing pathways like "response to viruses", "positive regulation of defence response", "regulation of immune innate response" and "response to interferon gamma" are among the most dysregulated.

5. Conclusions {#s0075}
==============

Our previous work on up- and down-regulated genes and functions, immediately after 24 hours exposure to 1 μM CdCl~2~ and after a period of recovery, showed that the cells respond mainly by activating defence mechanisms, that decrease in the following recovery period. These defence mechanisms are generally very efficient, however a few cells evade them and proliferate or survive in an uncontrolled manner ([@bb0060]; [@bb0020]). This leads to the formation of *foci* derived from different transformed cell clones. The features of deregulated genes in each *focus,* analyzed in this work, suggest that different functional targets (proteins and/or processes) are involved in the complex mechanism of cell transformation. However, it is noteworthy that the only genes in common to all analyzed *foci* are those responsible for cytokine/chemokines coding. These genes are involved in the inflammatory response, which is a known feature of carcinogenesis (see for example ([@bb0045]; [@bb0300]). In addition, in F3 *focus* the inflammatory response is likely related to mitochondrial damage.

Thus, it appears that the significant signal triggering the process of Cd-induced transformation in C3H cells could be mainly represented by the deregulation of zinc homeostasis. The interference of Cd on Zn homeostasis has previously been demonstrated by our group and is also described in the literature ([@bb0020]; [@bb0335]; [@bb0200]). Moreover, our present work stresses the relevance of the cell transformation assays (CTAs) not only as *in vitro* methods for the evaluation of the carcinogenesis potential of chemicals, but also as powerful tools for the comprehension of the mechanisms underlying the process of cell transformation.

The *in vitro* and bioinformatics mechanistic-based approach of this work, along with novel integrated *in vitro* carcinogenicity test on multiple cellular endpoints ([@bb0385]) is in agreement with the just published suggestions ([@bb0185]) on performing *ad hoc* studies sorted on the basis of cancer's hallmarks, and organised in the form of Integrated Approaches to Testing and Assessment (IATA). This would provide a better understanding of cancer induction by environmental contaminants, also in view of its prevention, and could progress the exploit of *in vitro* carcinogenicity evaluation.

Further, although our work is preliminary and additional studies will be necessary, the identification of specific structures/processes deregulated in transformed cells could represent an important starting point for the development of anti-tumour agents targeting specific cell functions in transformed cells. In this context, the use of CTAs represents an invaluable means to perform preliminary studies in a controlled and relatively simple environment, in comparison to the *in vivo* situation.
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